Abstract
Background
The plant origin capsaicinoids (capsaicin, dihydrocapsaicin, norcapsaicin, dihydrocapsaicin, homocapsaicin, homodihydrocapsaicin) are well known and used as nutritional additive agents in the every day nutritional practice from the last 9,500 years; however, we had have a very little scientifically based knowledge on their chemistry, physiology and pharmacology in animal observations, and in humans up to the mid-twentieth century. Our knowledge about their chemistry, physiology, pharmacology entered to be scientifically based evidence from the year 1980, dominantly in animal observations. The human observations with capsaicin (capsaicinoids), in terms of good clinical practice, have been started only in the last 10-year period (from 1997) in randomized, prospective, multiclinical studies. The name of “capsaicin” used only in the physiological and pharmacological research both in animal experiments and in human observation. The “capsaicin” (as a “chemically” used natural compound) modifies the so-called capsaicin-sensitive afferent nerves depending on their applied doses.
Aims
The specific action of capsaicin (capsaicinoids) on sensory afferent nerves modifying gastrointestinal (GI) function (under very specific conditions) offers a possibility for the production of an orally applicable drug or for other drug combinations, which can be used in the human medical therapy. The production of new drug is based on the critical interdisciplinary review of the results obtained with capsaicinoids.
Materials and methods
This paper gives an interdisciplinary and critical overview on the chemical, physiological, pharmacological and toxicological actions of the natural origin capsaicinoids (from the point of drug production) under conditions of acute, subacute and chronic administration in animal experiments and human observations, toxicology, pharmacokinetics). This interdisciplinary review covers the following main chapters: (1) physiological and pharmacological research tool by capsaicin in the animals and human beings, (2) capsaicin research in animals (including the acute, subacute toxicology and chronic toxicology metabolism, genotoxicology), (3) capsaicin observation with capsaicin in human beings.
Conclusion
(1) The capsaicin used in the physiological and pharmacological observations (in animals and human beings) chemically represents different chemical compounds, which can be obtained from the plants (paprika, chilli, etc.), (2) capsaicinoids are able to modify the capsaicin-sensitive afferent nerves, which have principle roles in the defence of different organs (including the gastrointestinal tract [against the different chemicals, heat, strech, chemical millieu-induced damage], (3) the application of capsaicin (capsaicinoids) can be repeated for the beneficial effects on the gastrointestinal tract as those in animal experiments. After this interdisciplinary and critical review, this paper demonstrates the well-planned research pathways of the discoveries of capsaicinoids from plant chemistry, via physiology, pharmacology and toxicology in animal experiments and human observations.
Similar content being viewed by others
References
Abdel-Salam OME, Szolcsányi J, Barthó L, Mózsik Gy. Sensory nerve-mediated mechanisms, gastric mucosal damage and its protection: a critical overview. Gastroprotection. 1994;2:4–12.
Abdel-Salam OME, Mózsik Gy, Szolcsányi J. The effect of intragastrically administered capsaicin analogue in HCl and non-HCl dependent models of gastric mucosal injury. Z Gastroenterol. 1995a;33:80.
Abdel-Salam OME, Mózsik Gy, Szolcsányi J. Capsaicin and its analogue resiniferatoxin inhibit gastric acid secretion in pylorus-ligated rats. Pharmacol Res. 1995b;31:341–5.
Abdel-Salam OME, Mózsik Gy, Szolcsányi J. Effect of resiniferatoxin on stimulated gastric acid secretory responses in the rat. J Physiology (Paris). 1995c;88:353–8.
Abdel-Salam OME, Mózsik Gy, Szolcsányi J. Studies on the effect of intragastric capsaicin on gastric ulcer and on the prostacyclin-induced cytoprotection in rats. Pharmacol Res. 1995d;32:209–15.
Abdel Salam OME, Bódis B, Karádi O, Szolcsányi J, Mózsik Gy. Modification of aspirin and ethanol-induced mucosal damage in rats by intragastric application of resiniferatoxin. Inflammopharmacology. 1995e;3:135–47.
Abdel Salam OME, Bódis B, Karádi O, Szolcsányi J, Mózsik Gy. Nature of gastric H+ back-diffusion approached by cimetidine, vagotomy, RTX and sucralfate. Ceská Slovenská Gastroenterologie. 1995f;49:175–85.
Abdel Salam OME, Bódis B, Karádi O, Nagy L, Szolcsányi J, Mózsik Gy. Stimulation of capsaicin-sensitive sensory peripheral nerves with topically applied resiniferatoxin decreases salicylate-induced gastric H+ back-diffusion in the rat. Inflammopharmacology. 1995g;3:121–33.
Abdel Salam OME, Szolcsányi J, Mózsik Gy. Differences in action of topical and system cystamine on gastric blood flow, gastric acid secretion and gastric ulceration in the rat. J Physiology (Paris). 1996a;90:63–73.
Abdel-Salam OME, Szolcsányi J, Porszász R, Mózsik Gy. Effect of capsaicin and resiniferatoxin on gastrointestinal blood flow in rats. Eur J Pharmacol. 1996b;305:127–36.
Abdel-Salam OME, Mózsik Gy, Szolcsányi J. The effect of capsaicin and resiniferatoxin on the indomethacin-induced gastric mucosal damage in rats. In: Mózsik Gy, Nagy L, Király Á, editors. Cell injury and protection in gastrointestinal tract. From basic science to clinical perspectives. Dordrecht: Kluwer Academic Publisher; 1997a. p. 95–105.
Abdel-Salam OME, Mózsik Gy, Szolcsányi J. The role of afferent sensory nerve in gastric mucosal protection. In: Mózsik Gy, Nagy L, Király Á, editors. Twenty-five years of peptic ulcer research in Hungary. From basic science to clinical practice 1971–1995. Budapest: Akadémiai Kiadó; 1997b. p. 295–308.
Abdel-Salam OME, Szolcsányi J, Mózsik Gy. The effect of resiniferatoxin on experimental gastric ulcer in rats. In: Gaginella T, Mózsik Gy, Rainsford KD, editors. Biochemical pharmacology as approach to gastrointestinal disease. From basic science to clinical perspectives. Dordrecht: Kluwer Academic Publisher; 1997c. p. 269–85.
Abdel-Salam OME, Szolcsányi J, Mózsik Gy. The indomethacin-induced gastric mucosal damage in rats. Effect of gastric acid, acid inhibition, capsaicin-type agents and prostacyclin. J Physiology (Paris). 1997d;97:7–19.
Abdel-Salam OME, Debreceni A, Mózsik Gy. Capsaicin-sensitive afferent sensory nerves in modulating gastric mucosal defense against noxious agents. J Physiol. 1999;93:443–54.
Abdel-Salam OME, Czimmer J, Debreceni A, et al. Gastric mucosal integrity: Gastric mucosal blood flow and microcirculation. An overview. J Physiol. 2001;95:105–27.
Abdel-Salam OME, Sleem AA, Hassan NB, Sharaf HA, Mózsik Gy. Capsaicin ameliorates hepatic injury caused by carbon tetrachloride in the rat. J Pharmacol Toxicol. 2006;1:147–56.
Aijoka H, Miyake H, Matsuura N. Effect of FRG-8813, a new-type histamine H2-receptor antagonist, on the recurrence of gastric ulcer healing by drug treatment. Pharmacology. 2000;61:83–90.
Aijoka H, Matsuura N, Miyake H. High quality of ulcer healing in rats by lafutidine and new-type histamine H2-receptor antagonist: involvement of capsaicin of sensitive sensory neurons. Inflammopharmacology. 2002;10:483–93.
Alföldi P, Obál F Jr, Tóth E, Hideg J. Capsaicin pretreatment reduces the gastric acid secretion elicited by histamine but does not affect the responses to carbachol and pentagastrin. Eur J Pharmacol. 1986;123:321–632.
Alföldi P, Tóth E, Obál F, Hideg J. Capsaicin treatment reduces histamine-induced gastric acid secretion in the rat. Acta Physiol Hung. 1987;69:509–12.
Ames BN, McCann J, Yamasaki E. Methods for detecting carcinogens and mutagens with the Salmonella/microsoma test assay of 300 chemicals. Mutat Res. 1975;31:347–64.
Anonymous. Metabolism and toxicity of capsaicin. Nutr Rev. 1986;44:20–2.
Ato A, Yamamoto M. Acute oral toxicity of capsaicin in mice and rats. J Toxicol Sci. 1996;21:195–200.
Azizan A, Blevins RD. Mutagenicity and antimutagenicity testings of six chemicals associated with the pungent properties of specific spices as revealed by the Ames salmonella microsomal assay. Arch Environ Contam Toxicol. 1995;28:248–58.
Berkesy L. Effect of paprika on gastric secretion (in Hungarian). Orv Hetil Hung Weekly Med J. 1934;78:397–9.
Bevan S, Szolcsányi J. Sensory neuron-specific actions of capsaicin: mechanisms and application. Trends Pharmacol Sci. 1990;11:330–3.
Bevan S, Yeats J. Protons activate a cation conductance in a subpopulation of rat dorsal root ganglion neurons. J Physiology (London). 1990;433:145–61.
Bley KR. Recent developments in transient receptor potential vanilloid 1 agonist-based therapies. Expert Opin Investig Drugs. 2004;13:1445–56.
Boersch A, Calligham BA, Lembeck F, Sharman DF. Enzymatic oxidation of capsaicin. Biochem Pharmacol. 1991;41:1863–969.
Brash AR, Baertschi SW, Ingram Cd, Harris TM. Isolation and characterization of natural allene oxides: unstable intermediates in the metabolism of lipid hydroperoxides. Proc Natl Acad Sci USA. 1988;85:3382–6.
Bruggeman TM, Wood JG, Davenport HW. Local control of blood flow in the dog’s stomach: vasodilatation caused by acid back-diffusion following topical application of salicylic acid. Gastroenterology. 1979;77:736–44.
Buck SH, Burks TF. The Neuropharmacology of capsaicin: review of some recent observation. Pharmacol Rev. 1986;38:179–226.
Buck SH, Miller MS, Burks TF. Depletion of primary afferent substance P by capsaicin and dihydrocapsaicin without altered thermal sensitivity. Brain Res. 1982;233:216–20.
Buiatti E, Palli D, Dacarli A, Amaddori D, Avelini C, Biachi S, et al. A case-control study of gastric cancer and diet in Italy. Int J Cancer. 1989;44:611–6.
Cabanac M, Cormareche-Leyder M, Poirior LJ. The effect of capsaicin on the temperature regulation of the rat. Flügers Arch ges Physiol. 1976;366:217–21.
Castle NA. Differential inhibition of potassium currents in rat ventricular myocytes by capsaicin. Cardivasc Res. 1992;26:1137–44.
Caterina MJ, Schumacker MA, Tomigana M, Rosen TA, Levine JD, Julius D. Capsaicin receptor: a heat activated ion channel in the pain pathway. Nature. 1997;389:816–24.
Chanda S, Erexson G, Riach C, Innnes D, Stevenson F, Murli H, et al. Genotoxicity studies with pure trans-capsaicin. Mutat Res. 2004;557:85–97.
Chanda S, Mould A, Esmail A, Bley K. Toxicity studies with pure trans-capsaicin delivered to dogs via intravenous administration. Reg Toxicol Pharmacol. 2005;43:66–75.
Chard PS, Bleakman D, Saridge JR. Capsaicin-induced neurotoxicity in cultured dorsal root ganglion neurons: involvement of calcium-activated proteases. Neuroscience. 1995;65:1099–108.
Cheng YP, Wang YH, Cheng LP, He RR. Electrophysiologic effects of capsaicin on pacemaker cells in sinoatrial nodes of rabbits. Acta Pharmacol Sin. 2003;24:826–30.
Chudapongse P, Janthasoot W. Mechanism of the inhibitory action on capsaicin on energy metabolism by rat liver mitochondria. Biochem Pharmacol. 1981;30:735–40.
Clive D, Flamm WG, Machesko MR, Bernheim NJ. A mutational assay system using the thymidine kinase locus in mouse lymphoma cells. Mutat Res. 1972;16:77–87.
Clive D, Johnson KO, Spector JF, Batson AG, Brown MM. Validation and characterization of the L5178Y/TK± mouse lymphoma and mutagens assay system. Mutat Res. 1979;59:61–108.
Cordell GA, Araujo OD. Capsaicin: identification, nomenclature, and pharmacology. Ann Pharmacother. 1993;27:330–6.
Couzin J. Withdrawal of vioxx casts shadow over COX-1 inhibitors. Science. 2004a;306:3844–50.
Couzin J. Nail-biting time for trials of COX-2 drug. Science. 2004b;306:1673–5.
Csáky TZ. Introduction to general pharmacology. New York: Appleton Century-Craft Educational Division, Meredith Corporation; 1969. p. 17–34.
De AK, Ghosh JJ. Inflammatory responses induced by substance P in rat paw. Indian J Exp Biol. 1990;28:946–8.
De Lille J, Ramirez E. Pharmacodynamic action of the active principle of chilli (Capsicum annum). Chemistry. 1935;4836 (abstract).
Debreceni A, Juricskay I, Figler M, Abdel-Salam OME, Szolcsányi J, Mózsik Gy. A direct stimulatory effect of small dose of capsaicin on gastric emptying rate in healthy human subjects measured by 13C labeled octanoid acid breath test. J Physiol. 1999;93:455–60.
Desai HG, Venugopalam K, Anita FP. Effect of red chili powder on NDA content of gastric aspirates. Gut. 1973;14:974–6.
Dömötör A, Szolcsányi J, Mózsik Gy. Capsaicin and glucose absorption and utilization in healthy human subjects. Eur J Pharmacol. 2006;534:208–83.
Donnerer J, Lembeck F. Capsaicin-induced reflex fall in rat blood pressure is mediated by afferent substances P-containing neurones via a reflex centre in the brain stem. Naunyn-Schmiedeber’s Arch Pharmacol. 1983;324:293–5.
Donnerer J, Amann R, Schuligoi R, Lembeck F. Absorption and metabolism of capsaicinoids following intragastric administration in rats. Naunin-Schmiedeberg’s Arch Pharmacol. 1990;342:357–61.
Dugani AM, Galvin GB. Capsaicin effects on stress pathology and gastric acid secretion in rats. Life Sci. 1986;39:1531–8.
Endoh K, Leung FW. Topical capsaicin protects the distal but not the proximal colon against acetic acid injury. Gastroenterology. 1990;98:A 446.
Espinosa-Aquire JJ, Reyes RE, Rubio J, Ostrosky-Wegman P, Martinez G. Mutagenic activity of urban air samples and its modulation by chilli extracts. Mutat Res. 1993;303:55–61.
Esplugues JV, Whittle BJR. Morphine potentiation of ethanol-induced gastric mucosal damage in the rat. Role of local sensory afferent neurons. Gastroenterology. 1990;98:82–9.
Esplugues JV, Whittle BJR, Moncanda S. Local opioid-sensitive afferent sensory neurons in the modulation of gastric damage induced by PAF. Br J Pharmacol. 1989;97:579–85.
Esplugues JV, Ramos EG, Gil L, Esplugues J. Influence of capsaicin-sensitive afferent neurons on the acid secretory responses of the rat stomach in vivo. Br J Pharmacol. 1990;100:491–6.
Esplugues JV, Whittle BJR, Moncanda S. Modulation by opioids and by afferent sensory neurons of prostanoids protection of the rat gastric mucosa. Br J Pharmacol. 1992;106:846–52.
Evangelista S, Meli A. Influence of capsaicin-sensory fibres on experimentally-induced colitis in rats. J Pharm Pharmacol. 1989;41:574–6.
Evangelista S, Santicioli P, Maggi CA, Meli A. Increase in gastric acid secretion induced by 2-deoxy-d-glucose is impaired in capsaicin pretreated rats. Br J Pharmacol. 1989;98:35–7.
Evans HJ. Chromosomal aberrations produced by ionizing radiation. Int Rev Cytol. 1962;13:221–31.
Evans HJ. Cytological methods for detecting chemical mutagens. In: Hollander A, editor. Chemical mutagens, principles and methods for their detection, vol 4. New York: Plenum Press, 1976. p. 1–29.
Expert Consensus Document on the Use of Antiplatelet Agents. ESC Eur J 2004.
Fischer GA. Studies of the culture of leukemic cells in vitro. Ann N Y Acad Sci. 1958;76:673–80.
Flynn DL, Rafferty MF. Inhibition of human neutrophil 5-lipoxygenase activity by ginerdione, shogaol, capsaicin and related pungent compounds. Prostagland Leucotrien Med. 1986;24:195–8.
Freudenberg K. Research on lignin. Fortschr Chem Org Naturst. 1962;20:41–72.
Galloway SM, Aardema MJ, Ischidate M, Ivett JL Jr, Kirkland DJ, Morita T, et al. Report from working group on in vitro tests for chromosomal aberrations. Mutat Res. 1994;312:241–61.
Gislason H, Guttu K, Sorbye H, Schifter S, Waldum LH, Svanes K. Role of histamine and calcitonin gene-related peptide in the hyperemic response to hypertonic saline and H+ back-diffusion in the gastric mucosa of cats. Scand J Gastroenterol. 1995;30:300–10.
Glinsukon T, Stitmunnaitnum Y, Toskulkao C, Buranawuth T, Tandkrisanavinont V. Acute toxicity of capsaicin in several animal species. Toxicon. 1980;18:215–20.
Goso C, Evangelista S, Tramontana N, Manzini S, Blumberg PM, Szallasi A. Topical capsaicin protects against trinitrobenzene sulfonic acid-induced colitis in the rat. Eur J Pharmacol. 1993;249:185–90.
Govindarajan VS, Sathyanarayana MN. Capsicum-production, technology, chemistry, and quality. Part V. Impact on physiology, pharmacology, nutrition, and metabolism: structure pungency, pain, and desensitization sequences. Crit Rev Food Sci Nutr. 1991;29:435–74.
Gray JL, Bunnet NW, Orloff SL, Mulvihill SJ, Debas HT. Role for calcitonin gene-related peptide in protection against gastric ulceration. Ann Surg. 1994;219:58–64.
Guengerich FP, Kim DH, Iwasaki M. Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem Res Toxicol. 1991;4:168–79.
Gulbekian S, Merighi A, Wharton J, Varndell IM, Polak JM. Ultrastructural evidence for the coexistence of calcitonin gene-related peptide and substance P in secretory vesicles of peripheral nerves in the guinea-pig. J Neurocytol. 1986;15:535–42.
Gunnett PM, Shi X, Lawson T, Kolar C, Toth B. Aryl radical formation during the metabolism of arylhydrazines by microsomes. Chem Res Toxicol. 1997;10:1372–7.
Haim N, Nemec J, Roman J, Sinha BK. In vitro metabolism of etoposide (VP-16-213) by liver microsomes and irreversible binding of reactive intermediates to microsomal proteins. Biochem Pharmacol. 1987a;36:527–36.
Haim N, Nemec J, Roman J, Sinha BK. Peroxidase-catalyzed metabolism of etoposide (VP-15-213) and covalent binding of reactive intermediates to cellular macromolecules. Cancer Res. 1987b;47:5835–40.
Holzer P. Capsaicin-sensitive nerves in the control of vascular effector mechanisms. In: Green BG, Mason JR, Kare MR, editors. Chemical senses. Irritation, vol 2. New York: Marcel Dekker; 1990. p. 191–210. (TÉVES).
Holzer P. Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol Rev. 1991a;43:144–202.
Holzer P. Afferent nerve-mediated control of gastric mucosal blood flow and protection. In: Costa M, Surrenti C, Gorini S, Maggi CA, Meli A, editors. Sensory nerve and neuropeptides in gastroenterology. From basic science to clinical perspective. New York: Plenum Press; 1991b. p. 97–108.
Holzer P. Capsaicin: selective toxicity for thin primary sensory neurons. Selective neurotoxicity. In: Herken H, Hucho F, editors. Handbook of experimental pharmacology. Berlin: Springer; 1992a. p. 419–81.
Holzer P. Peptidergic sensory neurons in the control of vascular functions: mechanisms and significance in the cutaneous and splanchnic vascular beds. Rev Physiol Biochem Pharmacol. 1992b;121:50–146.
Holzer P. Neural emergency system in the stomach. Gastroenterology. 1998;114:823–39.
Holzer P. Capsaicin cellular targets, mechanisms of action, as selectivity for thin sensory neurons. Pharmacol Rev. 1999;43:143–201.
Holzer P, Sametz W. Gastric mucosal protection against ulcerogenic factors in the rat mediated by capsaicin-sensitive afferent neurons. Gastroenterology. 1986;91:975–81.
Holzer P, Lippe IT. Stimulation of afferent nerve endings by intragastric capsaicin protects against ethanol-induced damage of gastric mucosa. Neuroscience. 1988;27:981–7.
Holzer P, Pabst MA, Lippe IT. Intragastric capsaicin protects against aspirin-induced lesion formation and bleeding in the rat gastric mucosa. Gastroenterology. 1989;96:1425–33.
Iwama M, Tojima T, Iitol Y, Takahashi N, Kanke Y. Effects of capsaicin and ethanol on hepatic drug-metabolizing enzymes in rat. Int J Vit Nutr Res. 1990;60:100–3.
Jaiarj P, Kitphati C, Sinchaipanid N, Lertsin N, Siripanyachan P. Stability testing of capsaicinoid cream, Mahidol University Annual Research Abstracts 2000;371.
Jancsó N, Jancsó-Gábor A. Dauerausschaltung der Chemischen Schmerzempfindlichkeit durch capsaicin. Naunyn-Schmiedebergs Arch Exp Path Pharamc. 1959;236:142–5.
Jancsó N, Jancsó-Gábor A, Szolcsányi J. Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin. Br J Pharmacol. 1967;31:138–51.
Jancsó N, Jancsó-Gábor A, Szolcsányi J. The role of sensory nerves endings in the neurogen inflammation induced in human skin and in the eye and paw of the rat. Br J Pharmacol. 1968;33:32–41.
Jancsó-Gábor A, Szolcsányi J, Jancsó N. Irreversible impairment of the irregulation induced by capsaicin and similar pungent substances in rat and guinea-pigs. J Physiol (London). 1970;206:495–507.
Joe B, Lokesh BR. Role of capsaicin, curcumin and dietary n-3 fatty acids in lowering the generation of reactive oxygen species in rat peritoneal macrophages. Biochim Biophys Acta. 1994;1224:255–63.
Karádi O, Mózsik Gy. Surgical and chemical vagotomy on the gastrointestinal mucosal defense. Budapest: Akadémiai Kiadó; 2000.
Kawada T, Iwai K. In vivo and in vitro metabolism of dihydrocapsaicin, a pungent principle of hot pepper, in rat. Agric Biol Chem. 1985;49:441–8.
Kawada T, Suzuki T, Takahashi M, Iwai K. Gastrointestinal absorption and metabolism of capsaicin and dihydrocapsaicin in rats. Toxicol Appl Pharmacol. 1984;72:449–56.
Kawai S, Nishida S, Kato M, Furumaya Y, Okomoto T, Mizushima Y. Comparison of cyclooxigenase-1 and-2 inhibitory activities of nonsteroidal anti-inflammatory drugs using humaín platelets and synovial cells. Eur J Pharmacol. 1998;347:87–94.
Kensler TW, Egner PA, Davidson NE, Roebuck BD, Pikul A, Groopman JD. Modulation of aflatoxin metabolism, aflatoxin-N7-guanine formation, and hepatic tumorigenesis in rats fed ethoxyquin: role of induction of glutathione S-transferases. Cancer Res. 1986;46:3924–31.
Ketusinh O, Dhorranintra B, Juengjareon K. Influence of capsaicin solution on gastric acidities. Am J Protocol. 1966;17:511–5.
Koop DR. Oxidative and reductive metabolism by cytochrome P450 2E1. FASEB J. 1992;6:724–30.
Kopec SE, DeBellis RJ, Irwin RS. Chemical analysis of freshly prepared and stored capsaicin solutions: implications for tussigenic challenges. Pulm Pharmacol Ther. 2002;15:529–34.
Lawson T, Gannett P. The mutagenicity of capsaicin and dihydrocapsaicin in V79 cells. Cancer Lett. 1989;49:109–13.
Lee SS, Kumar S. Microsomes, drug oxidations, and chemical calcinogenesis, vol 2. In: Coon MJ, Conney AH, Estabrook RW, Gelboin HV, Gillette JR, O’ Brien PJ, editors. New York: Academic Press. 1980. p. 1009–1012.
Lee HY, Dawson MI, Claret FX, Holzer S. Evidence of retinoid signaling alteration involving the activator protein I in tumorigenic human bronchial epithelial cells and small cell. Cell Growth Differ. 1997;8:283–91.
Lee KR, Suyuki T, Kobashi M, Hasegawa K, Iwai K. Quantitative microanalysis of capsaicin, dihydrocapsaicin, nordihydrocapsaicin using mass fragmentography. J Cromatogr. 1976;123:119–28.
Lenzer J. FDA is incapable of protecting of US “against another vioxx”. Br Med J. 2004;329:1253.
Li DS, Raybould HE, Quintero E, Guth PH. Calcitonin gene-related peptide mediates the gastric hyperemic response to acid back-diffusion. Gastroenterology. 1992;102:1124–8.
Lippe IT, Holzer P. Participation of endothelium-derived nitric oxide but not prostacyclin in the gastric mucosal hypeaemic response due to acid back-diffusion. Br J Pharmacol. 1992;105:708–14.
Lippe IT, Pabst MA, Holzer P. Intragastric capsaicin enhances rat gastric acid elimination and mucosal blood flow by afferent nerve stimulation. Br J Pharmacol. 1989;96:91–100.
Lopez-Carrillo L, Lopez-Cervantes M, Bobles-Diaz G, Ramilez-Espitia A, Mohar-Betancourt A, Menses-Gratia A, et al. Capsaicin consumption Helicobacter pylori positivity and gastric cancer in Mexico. Int J Cancer. 2003;106:277–82.
Maga JA. Capsicum. Crit Rev Food Sci Nutr. 1975;177–199.
Maggi CA. Tachykinins and calcitonin gene-related peptide (CGRP) as co-transmitters released from peripheral endings of sensory nerves. Prog Neurobiol. 1995;45:1–98.
Maggi CA, Meli A. The sensory-efferent function of capsaicin-sensitive sensory neurons. Gen Pharmacol. 1988;19:1–43.
Maggi CA, Santicioli P, Geppetti P, Parlani M, Astolfi M, DelBianco E, et al. The effect of calcium free medium and nefidipine on the release of substance P-like immunoreactivity and contractions induced by capsaicin in the isolated guinea-pig bladder. Gen Pharmacol. 1989;40:445–56.
Makara GB, Frenkl CR, Somfai Z, Szepesházi K. Effect of capsaicin on the experimental ulcer in the rat. Acta Med Sci Hung. 1965;21:213–6.
Mans DR, Lafleur MV, Westmijze EJ, van Maanen JM, van Schaik MA, Lankelma J, et al. Formation of different reaction products with single-and double-stranded DNA by the ortho-quinone and the semi-quinone free radical of etoposide (VP-16–213). Biochem Pharmacol. 1991;42:2131–9.
Maron DM, Ames BN. Revised methods for the Salmonella mutagenicity test. Mutat Res. 1983;113:173–215.
Marques S, Oliveira NG, Chaveca T, Rueff J. Micronuclei and sister chromatid exchanges induced by capsaicin in human lymphocytes. Mutat Res. 2002;517:39–46.
Martin RL, McDermott SJ, Salmen HJ, Palmatier J, Cox BF, Gintant GA. The utility of hERG and repolarization assays in evaluating delayed cardiac repolarization: influence of multi-channel block. J Cardiovasc Pharmacol. 2004;43:369–79.
McGettigan P, Henry D. Cardiovascular risk and inhibition of cyclooxygenase. A system review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2 JAMA 2006;296 (http://www.jama.com, on 15 September 2006).
Merighi A, Polak JM, Gibson SJ, Gulbekian S, Valentino KL, Peirone SM. Ultrastructural studies on calcitonin gene-related peptide-, tachykinin- and somatostatin-immunoreactive neurons in rat dorsal root ganglia: evidence for colocalization of different peptides in single secretory granules. Cell Tiss Res. 1988;254:101–9.
Miller MS, Brendel K, Burks TF, Sipes IG. Interaction of capsaicinoids with drug-metabolizing systems. Relationship to toxicity. Biochem Pharmacol. 1983;32:547–51.
Modly CE, Das M, Don PS, Marcelo CL, Mukhtar H, Bickers DR. Capsaicin as an in vitro inhibitor of benzo(a)pyrene metabolism and its DNA binding in human and murine keratinocytes. Drug Metab Dispos. 1986;14:413–6.
Molnar J. Die pharmakologischen wirkungen des capsaicin, des schaf schmeckenden wirkstoffers im paprika. Arzeilmittel-Forsh. 1965;L5:718.
Molnar J, György L. Pulmonary hypertensive and other haemodynamic effect of capsaicin in the cat. Eur J Pharmacol. 1967;1:86–92.
Monsereenusorn Y. Subchronic toxicity studies of capsaicin and capsinum in rats. Res Commmun Chem Path Pharmacol. 2001;41:95–110.
Moore MM, Honna M, Clements J, Bolcsfoldi G, Cifone M, Delondchamp R, et al. Mouse thymidine kinase gene mutation assay: International workshop on genotoxicity test. Workgroup Report.-Plymouth, UK 2002. Mutat Res. 2003;540:127–40.
Mózsik Gy, Moron F, Jávor T. Cellular mechanisms of the development of gastric mucosal damage and of gastroprotection induced by prostacyclin in rats. A pharmacological study. Prostagland. Leukot. Med. 1982;9:71–84.
Mózsik Gy, Király Á, Sütö G, Vincze Á. ATP breakdown and resynthesis in the development of gastrointestinal mucosal damage and its prevention in animals and human (an overview of 25 years ulcer research studies). In: Mózsik Gy, Pár A, Kitajima M, Kondo M, Pfeiffer CJ, Rainsford KD, Sikiric P, Szabó S, editors. Cell injury and protection in the gastrointestinal tract: from basic science to clinical perspectives. Budapest: Akadémiai Kiadó; 1993. p. 39–80.
Mózsik Gy, Abdel-Salam OME, Bódis B, Karádi O, Nagy L, Szolcsányi J. Role of vagal nerve in defense mechanisms against NSAIDs-induced gastrointestinal mucosal damage. Inflammopharmacology. 1996a;4:151–72.
Mózsik Gy, Abdel-Salam OME, Bódis B, Karádi O, Király Á, Sütö G, et al. Gastric mucosal protective effects of prostacyclin and β-carotene, and their biochemical backgrounds in rats treated with ethanol and HCl in dependence of their doses and of their time after administration of necritizing agents. Inflammopharmacology. 1996b;4:361–78.
Mózsik Gy, Nagy L, Király Á, editors. Twenty-five years of peptic ulcer research in Hungary. from basic science to clinical practice 1971–1995. Budapest: Akadémiai Kiadó; 1997a. p. 1–448.
Mózsik Gy, Nagy L, Pár A, Rainsford KD, editors. Cell injury and protection in the gastrointestinal tract: from basic science to clinical perspectives. Dordrecht: Kluwer Academic Publisher; 1997b.
Mózsik Gy, Abdel-Salam OME, Szolcsányi J. Capsaicin-sensitive afferent nerves in gastric mucosal damage and protection. Budapest: Akadémiai Kiadó; 1997c.
Mózsik Gy, Debreceni A, Abdel-Salam OME, Szabó I, Figler M, Ludámy A, et al. Small doses capsaicin given intragastrically inhibit gastric secretion in healthy human subjects. J Physiol Paris. 1999;93:433–6.
Mózsik Gy, Vincze Á, Szolcsányi J. Four responses of capsaicin sensitive primary afferent neurons to capsaicin and its analog. Gastric acid secretion, gastric mucosal damage and protection. J Gastroenterol Hepatol. 2001;16:193–7.
Mózsik Gy, Belágyi J, Szolcsányi J. Capsaicin-sensitive afferent nerves and gastric mucosal protection in the human healthy subjects. A critical overview. In: Takeuchi K, Mózsik Gy, editors. India: Research Signpost Kerala. 2004a. p. 43–62.
Mózsik Gy, Pár A, Pár G, et al. Insight into the molecular pharmacology to drugs acting on the afferent and efferent fibres of vagal nerve in the gastric mucosal protection. In: Sikirič P, Seiwerth P, Mózsik Gy., Arakawa T, Takeuchi K, editors. Proceedings of the 11th International Conference. Monduzzi: Ulcer Research. 2004b. p. 163–168.
Mózsik Gy, Rácz I, Szolcsányi J. Gastroprotection induced by capsaicin in healthy human subjects. World J Gastroenterol. 2005;11:5180–4.
Mózsik Gy, Dömötör A, Abdel-Salam OME. Molecular pharmacological approach to drug actions on the afferent and efferent fibres of the vagal nerve in the gastric mucosal protection in rats. Inflammopharmacology. 2006;14:243–9.
Mózsik Gy, Szolcsányi J, Dömötör A. Capsaicin research as a new tool to approach of the human gastrointestinal physiology, pathology and pharmacology. Inflammopharmacology. 2007;15:232–45.
Mózsik Gy, Dömötör A, Past T, Vas V, Perjési P, Kuzma M, et al. Capsaicinoids: from the plant cultivation to the production of the human medical drug. Budapest: Akadémiai Kiadó; 2009.
Nagabhuslan M, Blide SV. Mutagenicity of chili extract and capsaicin in short term tests. Environ Mutagen. 1985;7:881–8.
Newmark HL. A hypothesis for dietary components as blocking agents of chemical carcinogenesis: plant phenolics and pyrole pigments. Nutr Cancer. 1984;6:58–70.
Newmark HL. Plant phenolics as inhibitors of mutational and precarcinogenic events. Can J Physiol Pharmacol. 1987;65:461–6.
Nopanitaya W. Effects of capsaicin in combination with diets of varying protein content on the duodenal absorptive cells of the rat. Am J Dig Dis. 1974;19:439–49.
Notani PN, Jayant K. Role of diet in upper aerodigestive tract cancers. Nutr Cancer. 1987;10:103–13.
Oi Y, Kawada T, Watanabe T, Iwai K. Induction of capsaicin- hydrolyzing enzyme activity in rat liver by continuous oral administration of capsaicin. J Agric Food Chem. 1992;40:467–70.
Onodera S, Shibata M, Tanaka, et al. Gastroprotective mechanisms of lafutidine, a novel anti-ulcer drug with histamine H2-receptor antagonist activity, Artneim Forsch. Drug Res. 1999;49:519–26.
Onodera S, Shibata M, Tanaka, et al. Gastroprotective activity of FRG-8813, a novel histamine H2-receptor antagonist, in rats. Jpn J Pharmacol. 2002;68:161–73.
Pabst MA, Schöninkle E, Holzer P. Ablation of capsaicin-sensitive afferent neurons impairs defense but not rapid repair of rat gastric mucosa. Gut. 1993;34:897–903.
Pan HL, Chen SR. Sensing tissue ischemia: another function for capsaicin receptors? Circulation 2004;60:1826–1831.
Park YH, Lee SS. Identification and characterization of capsaicin-hydrolyzing enzymes purified from rat liver microsomes. Biochem Mol International. 1994;34:351–60.
Pique JM, Esplugues JV, Whittle BJR. Influence of morphine or capsaicin pretreatment on rat gastric microcirculatory response to PAF. Am J Physiol. 1990;258:G352–7.
Rauf M, Bachmann E, Metwally SA. J Drug Res Egypt. 1985;16:29–36.
Raybould HE, Taché Y. Capsaicin-sensitive vagal afferent fibres and stimulation of gastric acid secretion in anesthetized rats. Eur J Pharmacol. 1989;167:237–43.
Reinshage M, Pate A, Sottili M, Nast C, Davis W, Muellr K, et al. Protective functions of extrinsic sensory neurons in acute rabbit experimental colitis. Gastroenterology. 1994;106:1208–14.
Richeux F, Cascante M, Ennamary, Sabourcau D, Creppy EE. Cytotoxicity and genotoxicity of capsaicin in human neuroblastoma cellsSHSY-5Y. Arch Toxicol. 1999;73:403–9.
Ritchie WP Jr. Mediators of bile acid induced alterations in gastric mucosal blood flow. Am J Surg. 1991;161:126–9.
Robert A, Olafsson AS, Lancaster C, Zhang W. Effects of capsaicin and of capsaicin denervation on gastric secretion and gastric lesions produced by ulcerogenic agents. Exp Clin Gastroenterol. 1991;1:5. Abst.
Rozin P. Getting to like the burn of chili pepper. Biological, physiological, and cultural perspective. In: Green BG, Manson JR, Kare MR, editors. Chemical senses. Irritation, vol. 2. New York: Marcel Dekker; 1990. p. 231–69.
Saito A, Yamamoto M. Acute oral toxicity of capsaicin in mice and rats. J Toxicol Sci. 1996;21:195–200.
Sarlós P, Rumi Gy, Szolcsányi J, Mózsik Gy, Vincze Á. Capsaicin prevents the indomethacin-induced gastric mucosal damage n human healthy subject. Gastroenterology. 2003;124(Suppl. 1):A-511.
Savitha G, Panchanathan S, Salimath BP. Capsaicin inhibits calmodulin-mediated oxidative burst in rat macrophages. Cell Signal. 1990;2:577–85.
Schneider MA, de Luca V, Gray SJ. The effect of spice ingestion upon the stomach. Am J Gastroenterlol. 1956;26:722–32.
Schweiggert U, Schieber A, Carle R. Effects of blanching and storage on capsaicinoid stability and peroxidase activity of hot chili peppers. Innovative Food Science and Emerging Technologies. 2006, September
Solanke TF. The effect of red pepper (Capsicum frutescens) on gastric acid secretion. J Surg Res. 1973;15:385–90.
Starlinger M, Schiessel R, Hung CR. H+ back-diffusion stimulating mucosal blood flow in the rabbit fundus. Surgery. 1981;89:232–6.
Surh YJ, Lee SS. Capsaicin a double-edged swort: toxicity, metabolism, and chemopreventive potential. Life Sci. 1995;56:1845–55.
Surh YJ, Ahn SH, Kim KC, Park JB, Sohn YW, Lee SS. Metabolism of capsaicinoids: evidence for aliphatic hydroxylation and its pharmacological implications. Life Sci. 1995;56:PL305–11.
Szállasi A, Blumberg M. Vanilloid (capsaicin) receptors and mechanisms. Pharmacol Rev. 1999;51:159–211.
Szolcsányi J. A pharmacological approach to elucidation of the role of different nerve fibres and receptor endings in mediation of pain. J Physiology (Paris). 1977;73:251–9.
Szolcsányi J. Capsaicin type pungent agents producing pyrexia. In: Milton AS, editor. Handbook of experimental pharmacology, vol 60. Pyretics and Antipyretics. Berlin: Springer; 1982. p. 437–78.
Szolcsányi J. Capsaicin-sensitive chemoceptive neural system with dual sensory-efferent function. In: Chahl LA, Szolcsányi J, Lembech F, editors. Antidromic vasodilatation and neurogenic inflammation. Budapest: Akadémiai Kiadó; 1984. p. 27–56.
Szolcsányi J. Sensory receptors and the antinociceptive effect of capsaicin. In: Hakanson R, Sundler F, editors. Tachykinin antagonists. Amsterdam: Elsevier; 1985. p. 45–54.
Szolcsányi J. Capsaicin, irritation, and desensitization: neurophysiological and future perspectives. In: Green BG, Mason JR, Kare MR, editors. Chemical senses. Irritation, vol 2. New York: Marcel Dekker. 1990a. p. 141–169.
Szolcsányi J. Effect of capsaicin, rediniferatoxin and piperine on ethanol-induced gastric ulcer of the rat. Acta Physiol Hung. 1990b;75:267–8.
Szolcsányi J. Actions of capsaicin on sensory receptors. In: Wood JN, editor. Capsaicin in the study of pain. London: Academic Press; 1993. p. 1–33.
Szolcsányi J. Capsaicin-sensitive sensory nerve terminals with local and systemic efferent functions: facts and scopes of unorthodox neuroregulatory mechanisms. In: Kumazawa T, Kumazawa L, Mizumura K, editors. The polymodal receptor—a gateway to pathological pain. Progress in brain research, vol 113. Amsterdam: Elsevier; 1996. p. 343–59.
Szolcsányi J. A pharmacological approach to elucidation of the role of different nerve fibres and receptor endings in mediation of pain. J Physiol Paris. 1997;73:251–9.
Szolcsányi J. Forty years in capsaicin research for sensory pharmacology and physiology. Neuropeptide. 2004;38:377–84.
Szolcsányi J, Barthó L. Impaired defense mechanisms to peptic ulcer in the capsaicin-desensitized rat. In: Mózsik Gy, Hänninen O, Jávor T, editors. Advances in physiological sciences, vol 29. Gastrointestinal defense mechanisms. Oxford and Budapest: Pergamon Press and Akadémiai Kiadó; 1981. p. 39–51.
Szolcsányi J, Pórszász R, Pethő G. Capsaicin and pharmacology of nociceptors. In: Besson JM, Besson G, Ollat H, editors. Peripheral neurons in nociception. Physicopharmacological aspects. Paris: John Libby Eurotext. 1994. p. 109–124.
Takeuchi K, Ohuchi T, Okabe S. Capsaicin-sensitive sensory neurons in healing of gastric lesions induced by HCl in rats. Dig Dis Sci. 1994;39:2543–6.
Takeuchi K. Unique profile of lafutidine: a novel histamine H2-receptor antagonist: mucosal protection throughout GI mucosal mediated by capsaicin-sensitive afferent nerves. Acta Pharmacol Sinica Suppl. 2006;27–35.
Taurog A, Dorris M, Doerge DR. Evidence for a radical mechanism in peroxidase-catalyzed coupling. I. Steady-state experiments with various peroxidases. Arch Biochem Biophys. 1994;315:82–7.
Todd PA, Clissold SP. Naproxen. A reappraisal of its pharmacology, and therapeutic use in rheumatic disease and pain states. Drugs. 1990;40:91–137.
Tominata M, Caterina MJ, Malmberg AB, Rosen TA, Gilbet H, Skinner K, et al. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron. 1998;21:531–43.
Tramontana M, Renzi D, Calabro A, Panerai C, Milani S, Surrenti C, et al. Influence of capsaicin-sensitive afferent fibres on acetic acid-induced chronic gastric ulcers in rats. Scand J Gastroenterol. 1994;29:406–13.
Vaishnava P, Wang DH. Capsaicin sensitive-sensory nerves and blood pressure regulation. Curr Med Chem Cardiovasc Hematol Agents. 2003;1:177–88.
Varga L. Action of various stimulants on gastric chemistry (in Hungarian). Orv Hetil Hung Med Weekly. 1936;80:702–4.
Viranuvatti V, Kalayasiri C, Chearani O. Effect of capsicum solution on human gastric mucosa as observed gastroscopically. Am J Gastroenterol. 1972;58:225–32.
Walpole CS, Wrigglesworth R, Bevan S, Campbell EA, Dray A, James IF, et al. Analogs of capsaicin with agonist activity as novel analgesic agents; structure-activity studies 1. The aromatic “A-region”. J Med Chem. 1993a;36:2362–72.
Walpole CS, Wrigglesworth R, Bevan S, Campbell EA, Dray A, James IF, et al. Analogs of capsaicin with agonist activity as novel analgesic agents; structure-activity studies 2. The amide bond “B-region”. J Med Chem. 1993b;36:2373–80.
Walpole CS, Wrigglesworth R, Bevan S, Campbell EA, Dray A, James IF, et al. Analogs of capsaicin with agonist activity as novel analgesic agents; structure-activity studies 3. The hydrophobic side chain “C-region”. J Med Chem. 1993c;36:2381–9.
Wehmeyer Y, Kasting GB, Powell JH, Kuhlenbeck DL, Underwood RA, Bowman LA. Applications of liquid chromatography with on-line radiochemical detection to metabolism studies on a novel class of analgesic. J Pharm Biomed Anal. 1990;8:177–83.
Whittle BJR. Mechanisms underlying gastric mucosal damage induced by indomethacin and bile salts, and the action of prostaglandins. Br J Pharmacol. 1977;60:455–60.
Whittle BJR, Lopez-Belmonte J. Interactions between the vascular peptide endothelin-1 and sensory neuropeptides on gastric mucosal injury. Br J Pharmacol. 1991;102:950–4.
Winter J. Characterization of capsaicin sensitive neurons in adult rat dorsal root ganglion culture. Neurosci Lett. 1987;80:134–40.
Wood JN, Winter J, James IF, Rang HPh, Yeats J, Bevan S. Capsaicin induced ion fluxes in dorsal root ganglion neurons in culture. J Neurosci. 1988;8:3208–20.
Yagi T. Inhibition by capsaicin of NADH-quinone oxidoreductases is correlated with the presence of energy-coupling site 1 in various organisms. Arch Biochem Biophys. 1990;281:305–11.
Acknowledgments
The study was supported by the grant from National Office for Research and Technology, “Pázmány Péter program” (RET-II 08/2005).
The authors express deeply their sincerely thanks to Ms. Victoria Vas and Mrs. Judit Szabo for their excellent helps in the preparation of this overview.
Author information
Authors and Affiliations
Corresponding author
Additional information
This paper is dedicated to professor K. D. Rainsford on the occasion of his Festschrift (see Inflammopharmacol, 2008; 16:286–324), remembering our common research interests and book publications in the last four decades.
Rights and permissions
About this article
Cite this article
Mózsik, G., Past, T., Abdel Salam, O.M.E. et al. Interdisciplinary review for correlation between the plant origin capsaicinoids, non-steroidal antiinflammatory drugs, gastrointestinal mucosal damage and prevention in animals and human beings. Inflammopharmacol 17, 113–150 (2009). https://doi.org/10.1007/s10787-009-0002-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10787-009-0002-3
Keywords
- Capsaicin
- Plant origin capsaicinoids
- Chemistry
- Methods for their identification physiology
- Pharmacology
- Toxicology
- Metabolism
- Genotoxicity studies
- Acute, subacute and chronic administration
- Expert opinion for preclinical dossier
- Production of a new drug (or drug combination) from plant origin capsaicinoids, NO-NSAIDs
- Gastrointestinal damage and prevention
- Locomotor system
- COX-1 and COX-2 enzyme systems and the drugs acting on them
- Human drugs therapy
- Prevention of the human diseases